AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 16,459 | 111,748 | 7,355 | 20,585 | 23,569 |
| Gross Profit | 16,459 | 111,748 | 7,355 | 20,585 | 23,569 |
| Operating Expenses | 81,799 | 66,922 | 58,015 | 43,492 | 34,185 |
| Operating Income | -65,340 | 44,826 | -50,660 | -22,906 | -10,616 |
| Interest Expense | 196 | 3,966 | 305 | 4,121 | 260 |
| Other Income | -509 | 4,878 | -1,128 | 186 | 3,671 |
| Pre-tax Income | -66,045 | 45,737 | -52,092 | -26,842 | -7,205 |
| Net Income Continuous | -66,045 | 45,737 | -52,092 | -26,842 | -7,205 |
| Net Income | $-66,045 | $45,737 | $-52,092 | $-26,842 | $-7,205 |
| EPS Basic Total Ops | -0.92 | 0.64 | -0.84 | -0.47 | -0.14 |
| EPS Basic Continuous Ops | -0.92 | 0.65 | -0.84 | -0.47 | -0.14 |
| EPS Diluted Total Ops | -0.92 | 0.64 | -0.84 | -0.47 | -0.14 |
| EPS Diluted Continuous Ops | -0.92 | 0.64 | -0.84 | -0.47 | -0.14 |
| EPS Diluted Before Non-Recurring Items | -0.92 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-63,242 | $46,108 | $-49,677 | $-22,317 | $-10,334 |